Algae Extract Skin Formulation for Moisture and Irritation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing cosmetics and skin care products, such as moisturizers, foundations, and cleansers, often cause skin irritation, dryness, and instability, failing to effectively improve skin moisture and appearance.
Innovation Solution
A topical composition combining hydrolyzed algae extract and saccharide isomerate, which increases filaggrin production, enhances skin moisture, increases occludin production, decreases skin permeability, inhibits TNFα production, and prevents oxidative damage, while being stable and dermatologically acceptable.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional moisturizers and skin care products are used, then skin moisture is attempted to be improved, but skin irritation and dryness occur
Solution Approach 1:
The patent changes the chemical parameters of the moisturizing composition by using hydrolyzed algae extract instead of conventional moisturizing agents. This parameter change allows the composition to provide moisturizing benefits without causing skin irritation or dryness, effectively resolving the technical contradiction between improving skin moisture and avoiding harmful effects.
Solution Approach 2:
The patent combines hydrolyzed algae extract with saccharide isomerate to create a composite moisturizing composition. This composite material approach synergistically enhances the moisturizing effect while minimizing skin irritation, as each component contributes different beneficial properties that together resolve the contradiction between moisture improvement and irritation prevention.
2Productivity
If cleansers with strong surfactants are used, then cleaning effectiveness is improved, but skin irritation and prolonged recovery periods occur
Solution Approach 1:
The patent changes the chemical composition parameters of cleansers by replacing strong surfactants with hydrolyzed algae extract and saccharide isomerate. This parameter change maintains cleaning effectiveness through the mild surfactant properties of the algae extract while eliminating the skin irritation and prolonged recovery periods associated with conventional strong surfactants.
3Reliability
If foundations and masks are applied to skin, then cosmetic coverage and treatment benefits are achieved, but skin drying and irritation occur
Solution Approach 1:
The patent formulates foundations and masks using a composite of hydrolyzed algae extract and saccharide isomerate. This composite material provides the cosmetic coverage and treatment benefits needed while simultaneously preventing skin drying and irritation, as the saccharide isomerate component helps maintain skin moisture levels even when the product is left on the skin.
Solution Approach 2:
The patent changes the moisturizing parameters of leave-on cosmetic products by incorporating hydrolyzed algae extract, which provides sustained hydration. This parameter change ensures that foundations and masks maintain cosmetic effectiveness without causing the skin drying and irritation typically associated with conventional leave-on products.
4Shape
If exfoliating masks are used, then skin texture improvement is achieved, but skin sensitivity and dryness are exacerbated
Solution Approach 1:
The patent changes the exfoliation mechanism parameters by using hydrolyzed algae extract, which provides gentle exfoliation through its natural properties rather than harsh abrasives or strong chemicals. This parameter change improves skin texture while minimizing the exacerbation of skin sensitivity and dryness associated with conventional exfoliating masks.
Data Source
AI summary
A method of treating skin is disclosed. The method can include topically applying to a person's skin a composition comprising 0.0001% to 5% w/w of a hydrolyzed algae extract comprising exopolysaccharides from Halymenia durvillei, and 0.0001% to 5% w/w of a saccharide isomerate comprising an exopolysaccharide synthesized by Vibrio alginolyticus, wherein at least one of skin permeability is decreased, filaggrin production is increased, skin moisture is increased, occludin production is increased, or TNFα production is inhibited in the skin.